HEALTHFOX NEWS
Ozempic users may be making a major weight-loss mistake, new study suggests
A new study suggests that adults taking GLP-1 medications like Ozempic or Wegovy for weight loss are significantly reducing their physical activity, with decreases in daily steps and moderate-to-vigorous exercise. Researchers emphasize that exercise remains essential for preserving strength and long-term health when using these drugs, despite the observed decline in activity.
Mentioned
Related Signal
Adjacent reporting
- People taking GLP-1 weight loss drugs like Ozempic started moving less
- The real reason you're not getting skinny on weight-loss drugs like Ozempic and Wegovy... as scientists also discover who is most at risk for undesirable side effects
- Divorce boom may follow use of Ozempic and other GLP-1 drugs, experts warn
- Middle-aged adults taking GLP-1s for obesity can save over $192K on lifetime medical costs, higher if they don’t have college degrees, new study finds
- GLP-1 drugs linked to major slowdown in breast cancer, prostate cancer and more: new study
- Breaking down findings of new study on weight loss drugs and breast cancer